 Odonate Therapeutics NASDAQ:ODT was upgraded by stock analysts at ValuEngine from a sell rating to a hold rating in a research note issued to investors on Monday, ValuEngine reports. Other equities analysts also recently issued research reports about the stock. Goldman Sachs Group began coverage on shares of Odonate Therapeutics in a research note on ... 